drug summary · 5 NDC codes
Nucala 100 mg/mL
mepolizumab
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status BLA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
dataset id 108770NDC codes 5application BLA761122RxCUI —
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | mepolizumab |
|---|---|
| active ingredients | MEPOLIZUMAB |
| dosage form | INJECTION, SOLUTION |
| route | SUBCUTANEOUS |
| strength | 100 mg/mL |
| marketing status | BLA |
| DEA schedule | not reported |
| application number | BLA761122 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | GlaxoSmithKline LLC |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Interleukin-5 Antagonist [EPC]; Interleukin-5 Antagonists [MoA] |
NDC codes
5 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 00173089201 | — |
| 00173089242 | — |
| 00173089261 | — |
| 00173089263 | — |
| 0173-0892 | — |
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.